These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 12747581)
21. Pharmacogenetics and pharmacogenomics in the discovery and development of medicines. Roses AD Novartis Found Symp; 2000; 229():63-6; discussion 66-70. PubMed ID: 11084930 [No Abstract] [Full Text] [Related]
22. Pharmacogenomics and the drug discovery pipeline: when should it be implemented? Penny MA; McHale D Am J Pharmacogenomics; 2005; 5(1):53-62. PubMed ID: 15727489 [TBL] [Abstract][Full Text] [Related]
23. Convergent Functional Genomics of bipolar disorder: from animal model pharmacogenomics to human genetics and biomarkers. Le-Niculescu H; McFarland MJ; Mamidipalli S; Ogden CA; Kuczenski R; Kurian SM; Salomon DR; Tsuang MT; Nurnberger JI; Niculescu AB Neurosci Biobehav Rev; 2007; 31(6):897-903. PubMed ID: 17614132 [TBL] [Abstract][Full Text] [Related]
25. DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDA. Lesko LJ; Zineh I Pharmacogenomics; 2010 Apr; 11(4):507-12. PubMed ID: 20350131 [TBL] [Abstract][Full Text] [Related]
30. Genetics and genomics: the scientific drivers of personalized medicine. Kurnat-Thoma EL Annu Rev Nurs Res; 2011; 29():27-54. PubMed ID: 22891497 [TBL] [Abstract][Full Text] [Related]
32. Recent Advances and Emerging Applications in Text and Data Mining for Biomedical Discovery. Gonzalez GH; Tahsin T; Goodale BC; Greene AC; Greene CS Brief Bioinform; 2016 Jan; 17(1):33-42. PubMed ID: 26420781 [TBL] [Abstract][Full Text] [Related]
33. Clinical Implementation of Pharmacogenomics for Personalized Precision Medicine: Barriers and Solutions. Klein ME; Parvez MM; Shin JG J Pharm Sci; 2017 Sep; 106(9):2368-2379. PubMed ID: 28619604 [TBL] [Abstract][Full Text] [Related]
34. Insights into pharmacogenomics and its impact upon immunosuppressive therapy. Yagil Y; Yagil C Transpl Immunol; 2002 May; 9(2-4):203-9. PubMed ID: 12180832 [TBL] [Abstract][Full Text] [Related]
35. Pharmacogenomics in the assessment of therapeutic risks versus benefits: inside the United States Food and Drug Administration. Zineh I; Pacanowski MA Pharmacotherapy; 2011 Aug; 31(8):729-35. PubMed ID: 21923598 [TBL] [Abstract][Full Text] [Related]
36. Pharmacogenetics: past, present and future. Pirmohamed M Drug Discov Today; 2011 Oct; 16(19-20):852-61. PubMed ID: 21884816 [TBL] [Abstract][Full Text] [Related]
37. Methods to analyze big data in pharmacogenomics research. Li R; Kim D; Ritchie MD Pharmacogenomics; 2017 Jun; 18(8):807-820. PubMed ID: 28612644 [TBL] [Abstract][Full Text] [Related]
38. Pharmacogenetics and pharmacogenomics: development, science, and translation. Weinshilboum RM; Wang L Annu Rev Genomics Hum Genet; 2006; 7():223-45. PubMed ID: 16948615 [TBL] [Abstract][Full Text] [Related]
39. Genomic medicine implementation: learning by example. Williams MS Am J Med Genet C Semin Med Genet; 2014 Mar; 166C(1):8-14. PubMed ID: 24616394 [TBL] [Abstract][Full Text] [Related]
40. Do pharmacogenetics, genomics and epigenetics hold promise for molecular therapeutics and health? Huber LA Curr Opin Mol Ther; 2010 Jun; 12(3):268-9. PubMed ID: 20556904 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]